NU100 is a proprietary recombinant human interferon beta-1b (IFN beta-1b) which utilizes the company’s refolding process technology being developed as a new molecular entity. The double-blind, placebo-controlled, randomized
In order to eradicate and predict HIV, investigators of both companies decided to develop methods to characterize potential latency candidates and discover and validate targets and pathways to
The NOA will allow the California- based biotech company to identify differentially expressed proteins in cell samples. The method, which uses libraries of antibodies, has a wide range
GSK will provide funding and certain milestone payments to Alnylam, as per the deal. VaxiRNA is an RNAi technology for the enhanced production of viruses used in the
DB959 is a peroxisome proliferator activated receptor (PPAR)-delta/gamma agonist which activates certain nuclear receptors that regulate the genes involved in controlling blood sugar levels and certain lipids. The
The new drug will inhibit two protein kinase enzymes, TBK1 and IKKe, which will suppress the growth of certain cancer cell lines. The project aims to identify a
The technologies were developed by Hawaii Biotech and acquired by Merck in 2010. Hawaii Biotech CEO Elliot Parks said the licenses would help in the development of vaccines
The company decided to move in order to support its ongoing growth and to expand its business. The headquarters move brings the company to a resident where several
The generic version of Lamictal XR is an anticonvulsant drug which is indicated for the treatment of epilepsy. Intellipharmaceutics CEO Isa Odidi said their Hypermatrix technology platform continues
INNO-206 is a novel conjugate of doxorubicin that binds covalently to albumin, the most abundant protein in blood plasma, and is circulated throughout the body. Patients received three
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.